Boehringer Ingelheim UK public portal
patients, carers and members of the public
The purpose of this website is to provide reference information on Boehringer Ingelheim medicines. It is not intended to replace the opinion of a healthcare professional. Please consult your doctor, nurse or pharmacist for further information.
If you are looking for general information on Boehringer Ingelheim in the UK, please visit our [corporate UK website](/content/uk "corporate UK website"/index.html).
Actilyse® (alteplase)
Empagliflozin
Linagliptin
Metalyse® (tenecteplase)
Ofev® (nintedanib esilate)
Spiolto® Respimat® (tiotropium & olodaterol)
Spiriva® Respimat® (tiotropium)
Side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any side effects not listed in package leaflet.
You can also report side effects directly to the Yellow Card scheme of www.mhra.gov.uk/yellowcard
By reporting side effects you can help provide more information on the safety of the medicine.
Vault id: NP-GB-105222
Welcome to Boehringer Ingelheim
So that we can provide you with the most appropriate information on our medicines please confirm who you are:
Please select an option to continue: